首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Differential capacities of the RGS1, RGS16 and RGS-GAIP regulators of G protein signaling to enhance alpha2A-adrenoreceptor agonist-stimulated GTPase activity of G(o1)alpha.
【24h】

Differential capacities of the RGS1, RGS16 and RGS-GAIP regulators of G protein signaling to enhance alpha2A-adrenoreceptor agonist-stimulated GTPase activity of G(o1)alpha.

机译:G蛋白信号的RGS1,RGS16和RGS-GAIP调节剂的差异能力增强α2A-肾上腺素受体激动剂刺激G(o1)alpha的GTPase活性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Recombinant RGS1, RGS16 and RGS-GAIP, but not RGS2, were able to substantially further stimulate the maximal GTPase activity of G(o1)alpha promoted by agonists at the alpha2A-adrenoreceptor in a concentration-dependent manner. Kinetic analysis of the regulation of an alpha2A-adrenoreceptor-G(o1)alpha fusion protein by all three RGS proteins revealed that they had similar affinities for the receptor-G protein fusion. However, their maximal effects on GTP hydrolysis varied over threefold with RGS16 > RGS1 > RGS-GAIP. Both RGS1 and RGS16 reduced the potency of the alpha2A-adrenoreceptor agonist adrenaline by some 10-fold. A lower potency shift was observed for the partial agonist UK14304 and the effect was absent for the weak partial agonist oxymetazoline. Each of these RGS proteins altered the intrinsic activity of both UK14304 and oxymetazoline relative to adrenaline. Such results require the RGS interaction with G(o1)alpha to alter the conformation of the alpha2A-adrenoreceptor and are thus consistent with models invoking direct interactions between RGS proteins and receptors. These studies demonstrate that RGS1, RGS16 and RGS-GAIP show a high degree of selectivity to regulate alpha2A-adrenoreceptor-activated G(o1)alpha rather than G(i1)alpha, G(i2)alpha or G(i3)alpha and different capacities to inactivate this G protein.
机译:重组RGS1,RGS16和RGS-GAIP,但不是RGS2,能够以浓度依赖的方式实质上进一步刺激激动剂在α2A-肾上腺素受体上促进的G(o1)α的最大GTPase活性。通过所有三个RGS蛋白对alpha2A-肾上腺素能受体-G(o1)alpha融合蛋白进行调节的动力学分析表明,它们对受体-G蛋白融合具有相似的亲和力。然而,它们对GTP水解的最大影响是RGS16> RGS1> RGS-GAIP的三倍。 RGS1和RGS16都将α2A肾上腺素受体激动剂肾上腺素的效力降低了约10倍。对于部分激动剂UK14304,观察到较低的效力变化,而对于弱的部分激动剂羟甲唑啉则没有这种作用。相对于肾上腺素,这些RGS蛋白均改变了UK14304和羟甲唑啉的内在活性。此类结果要求RGS与G(o1)alpha相互作用以改变alpha2A-肾上腺素受体的构象,因此与调用RGS蛋白与受体之间直接相互作用的模型一致。这些研究表明,RGS1,RGS16和RGS-GAIP显示出高度的选择性来调节α2A-肾上腺素受体激活的G(o1)alpha而不是G(i1)alpha,G(i2)alpha或G(i3)alpha使G蛋白失活的能力。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号